Polomar Health Services (PMHS) Enterprise Value (2022 - 2026)
Polomar Health Services (PMHS) posted Enterprise Value of $3.2 million for Q2 2026, down 26.95% on a QoQ basis from $4.4 million in Q1 2026, and down 72.6% year-over-year from $11.7 million in Q2 2025.
Analysis
Polomar Health Services (PMHS) Enterprise Value (2022 - 2026) Analysis & Trends
Polomar Health Services has reported Enterprise Value for 5 years, with the latest figure at $3.2 million in Q2 2026.
- On a quarterly basis, Enterprise Value fell 72.6% year-over-year to $3.2 million in Q2 2026; TTM through Jun 2026 was $3.2 million, a 72.6% decrease from a year earlier, with the FY2025 full-year figure at $22.3 million, up 1054.68% from the prior year.
- Enterprise Value was $3.2 million for Q2 2026 at Polomar Health Services, down from $4.4 million in the prior quarter.
- The five-year high for Enterprise Value was $5.8 billion in Q4 2022, with the low at $1.9 million in Q4 2024.
- Average Enterprise Value over 5 years is $492.9 million, with a median of $19.9 million recorded in 2023.
- The largest YoY upside for Enterprise Value was 3744.34% in 2023 against a maximum downside of 99.7% in 2023.
- Over 5 years, Enterprise Value stood at $5.8 billion in 2022, then tumbled by 99.7% to $17.6 million in 2023, then tumbled by 89.03% to $1.9 million in 2024, then jumped by 1054.68% to $22.3 million in 2025, then tumbled by 85.57% to $3.2 million in 2026.
- The last three Enterprise Value figures came in at $3.2 million (Q2 2026), $4.4 million (Q1 2026), and $22.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | Polomar Health Services | 5.66 Mn | 5.48 Mn | 935,916.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.21 Mn |
| Mar 31, 2026 | 4.40 Mn |
| Dec 31, 2025 | 22.28 Mn |
| Sep 30, 2025 | 5.57 Mn |
| Jun 30, 2025 | 11.73 Mn |
| Mar 31, 2025 | 10.66 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Sep 30, 2024 | 37.32 Mn |
| Jun 30, 2024 | 161.50 Mn |
| Mar 31, 2024 | 163.68 Mn |
| Dec 31, 2023 | 17.60 Mn |
| Sep 30, 2023 | 145.12 Mn |
| Jun 30, 2023 | 386.46 Mn |
| Mar 31, 2023 | 1.07 Bn |
| Dec 31, 2022 | 5.84 Bn |
| Sep 30, 2022 | 3.77 Mn |